Nanomedicine for improvement of dendritic cell-based cancer immunotherapy.
Hashemi V, Farhadi S, Ghasemi Chaleshtari M, Seashore-Ludlow B, Masjedi A, Hojjat-Farsangi M, Namdar A, Ajjoolabady A, Mohammadi H, Ghalamfarsa G, Jadidi-Niaragh F.
Hashemi V, et al. Among authors: ghalamfarsa g.
Int Immunopharmacol. 2020 Jun;83:106446. doi: 10.1016/j.intimp.2020.106446. Epub 2020 Mar 31.
Int Immunopharmacol. 2020.
PMID: 32244048
Review.